Cancer treatment company plans for public offeringJuly 25, 2019PetCure Oncology has engaged Boustead Securities for a Regulation D 506(c) offering.
SPONSORED CONTENTNu.Q® Vet Cancer Test on the Element i+™ – the cancer detective in your clinicTo help elucidate the benefits of this test, Dr. Graham Bilbrough has compiled some common questions from veterinarians about Nu.Q. +